Scope of the Study
CPAP is known as continuous positive airway pressure. It is a treatment for obstructive sleep apnea. A CPAP machine uses a hose and mask in order to deliver constant as well as steady air pressure. Rising prevalence of sleep apnea globally due to the increase of lifestyle diseases, various initiatives by market players, the government initiative to increase awareness regarding sleep apnea, and the various technological advancements are likely to drive the CPAP market in the upcoming years.
The market study is being classified by Type (Fixed Pressure CPAP Device and Auto Adjusting CPAP Device), by Application (Residential, Hospital and Others) and major geographies with country level break-up.
ResMed (United States), Philips Respironics (Japan), Fisher & Paykel Healthcare Corporation Limited (New Zealand), DeVilbiss Healthcare LLC (United States), Apex Systems, Inc. (United States), Teijin Pharma (Japan), Covidien (Ireland), Koike Medical (Japan), Shanghai Fosun Pharmaceutical Co., Ltd., (China) and BMC Medical (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Beyond Medical (United States).
The market is fragmented with numerous players focusing on technique and quality of the product due to which the global CPAP market can witness an upsurge in the forecast period Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global CPAP Machines market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global CPAP Machines market by Type, Application and Region.
On the basis of geography, the market of CPAP Machines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- Large Pool of Undiagnosed Sleep Apnea Patients
- Rising Awareness about the Ill Effects of Untreated Sleep Apnea
- Rise Use of Oral Appliances
- Technological Advancements in Sleep Apnea Devices
- Influx of Venture Capital Funding
- Growing Company Interest in the Sleep Apnea Market
- Technology Advancement in CPAP Machines
- Complex Referral Pathways and Long Waiting Periods
- Rising Focus on Home Healthcare
- Growing Demand from Emerging Economics such as India, China, and others
- Lack of Patient Compliance
In April 2019, the Royal Philips Company has launched DreamWisp products, which allows patients with sleep apnea to sleep in any position. Hence, it will benefit the increased product portfolio of the company. and In December 2017, the Motif Medical Company has launched CPAP Products, which provides obstructive sleep apnea. Therefore, this product launch will help in strengthening the position of the company.
Key Target AudienceMedical devices manufacturing companies, Medical devices suppliers and distributors, Diagnostic laboratories, Hospitals, Venture capitalists, Sleep laboratories and Business research and consulting service providers
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase